The Contribution Of Maternal Obesity And Gestational Weight Gain To Preschool Child Obesity
Funder
National Health and Medical Research Council
Funding Amount
$697,213.00
Summary
Obesity affects more than 43 million children 0-5 years world-wide, and 21% of Australian children 2-3 years of age. The intra-uterine environment plays a key role in the development of later health and disease, representing a critical period in the subsequent programming of obesity. We will evaluate health outcomes (including growth/adiposity) for infants at 3 years, whose mother’s participated in a randomised trial evaluating an antenatal dietary intervention to limit gestational weight gain.
One Size Does Not Fit All: Personalised Exercise Strategies To Improve Cardiovascular And Metabolic Health In Patients With Non-alcoholic Fatty Liver Disease.
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
Non-alcoholic fatty liver disease (NAFLD) affects one third of Australian adults and is linked with numerous chronic health conditions. Regular exercise reduces NAFLD, even without weight loss. However, response to exercise therapy is highly variable and there is a need for more personalised approaches. This research will identify which personalised exercise strategies effectively treat NAFLD, and, which measures can accurately monitor the progression of the disease in clinical practice.
Metformin And Dietary Advice To Improve Insulin Sensitivity And Promote Gestational Restriction Of Weight In Pregnant Women Who Are Obese: The GRoW Randomised Trial
Funder
National Health and Medical Research Council
Funding Amount
$1,710,437.00
Summary
Obesity is a significant health issue during pregnancy and childbirth associated with well documented risks. Women who are obese commence pregnancy in a state of increased insulin resistance, the altered metabolic and inflammatory environment providing an excess of nutrients, and a stimulus to fetal growth. The aims of the GRoW randomised trial are to evaluate the effects of metformin and dietary advice to improve insulin sensitivity in obese pregnant women on health outcomes.
Inflammatory Mediators Of Liver Injury In Chronic Hepatitis C
Funder
National Health and Medical Research Council
Funding Amount
$349,336.00
Summary
Presently, liver disease from chronic hepatitis C and obesity represents a major health problem. Overall, approximately 50% of Australians with chronic hepatitis C are obese and these patients are at significantly increased risk of rapidly progressing to liver failure. It is now recognized that fat derived factors play an important role in regulating inflammatory responses. This grant proposal aims to gain insight into how liver and fat derived inflammatory factors interact to promote increased ....Presently, liver disease from chronic hepatitis C and obesity represents a major health problem. Overall, approximately 50% of Australians with chronic hepatitis C are obese and these patients are at significantly increased risk of rapidly progressing to liver failure. It is now recognized that fat derived factors play an important role in regulating inflammatory responses. This grant proposal aims to gain insight into how liver and fat derived inflammatory factors interact to promote increased liver damage in chronic hepatitis C and obesity.Read moreRead less
Central Neural Mechanisms Underlying The Effect Of Endocannabinoids On Body Weight
Funder
National Health and Medical Research Council
Funding Amount
$377,793.00
Summary
Obesity and its associated pathologies of cardiovascular and respiratory disease, stroke, predisposition to some cancers and infertility in women no longer needs to be justified as a major health issue in modern societies. In fact it is quickly becoming recognised as the major threat to world health. Recently, the anecdotal evidence for increased food intake, particularly the craving of high carbohydrate, high sugar foods, associated with the use of marijuana has been put into a therapeutic cont ....Obesity and its associated pathologies of cardiovascular and respiratory disease, stroke, predisposition to some cancers and infertility in women no longer needs to be justified as a major health issue in modern societies. In fact it is quickly becoming recognised as the major threat to world health. Recently, the anecdotal evidence for increased food intake, particularly the craving of high carbohydrate, high sugar foods, associated with the use of marijuana has been put into a therapeutic context. Specifically a cannabinoid receptor antagonist, rimonabant (currently undergoing trials as Accomplia) has become a central player in the race for an obesity therapy because of its effects in blocking the brain receptors that would normally respond to cannabinoid like compounds in the brain that tend to increase food intake. Despite the trials that are underway in Europe and the USA many of the central actions of the naturally occurring cannabinoids in the brain, the so-called endocannabinoids are very poorly understood. This series of experiments utilizing the best technologies available will address basic questions relating to the brain pathways involved and even the extent to which weight loss associated with the administration of these drugs to rats and presumably humans is dependent on the reduction of food intake or the burning of energy in a process called thermogenesis. These are essential pieces of information if this type of compound is to be considered as a serious contender in the search for an obesity therapyRead moreRead less
Over a research career currently spanning 44 years, the single unifying theme of my research has been the regulation of steroid hormone biosynthesis. Since 1993, the focus of my laboratory has been oestrogen biosynthesis. We study three main areas: i) the
This research will elucidate pathways in the brain that control satiety, in particular the role of neuropeptide Y and the satiety hormones peptide YY and pancreatic polypeptide. By understanding how satiety is controlled, this process could be stimulated for potential use as a novel treatment strategy for obesity or anorexia.
Birth Outcomes And Body Composition In Babies Born To Mothers With Diabetes In Pregnancy
Funder
National Health and Medical Research Council
Funding Amount
$109,358.00
Summary
This study will evaluate outcomes and body composition in neonates born to mothers who have diabetes during their pregnancy in the Northern Territory. Babies born to mothers with diabetes may be at higher risk of complications during birth and later in life may have increased risk of obesity and diabetes, conditions which are particularly prevalent in the Indigenous population and contribute to high morbidity and mortality rates. This study will be important to evaluate these factors, particular ....This study will evaluate outcomes and body composition in neonates born to mothers who have diabetes during their pregnancy in the Northern Territory. Babies born to mothers with diabetes may be at higher risk of complications during birth and later in life may have increased risk of obesity and diabetes, conditions which are particularly prevalent in the Indigenous population and contribute to high morbidity and mortality rates. This study will be important to evaluate these factors, particularly in a high risk population.Read moreRead less